Skip to content

Clinical trials

Phase 3 Prostatic Neoplasms trials in Greece

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 3 Country / region: Greece Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20031
20081
20095
20103
20111
20131
20141
20161
20171
20201
20222
20231
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Active, not recruiting5
Recruiting4
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen3
Bristol-Myers Squibb3
Pfizer3
Abbott2
Ferring Pharmaceuticals2
Merck Sharp & Dohme LLC2
Millennium Pharmaceuticals, Inc.2
Active Biotech AB1
Astellas Pharma Europe Ltd.1
AstraZeneca1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms26
Neoplasm Metastasis3
Neoplasms2
Bone Diseases, Metabolic1
Cataract1
Osteoporosis1
Recurrence1
Urogenital Neoplasms1

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.